Treatment of gastric precancerous change by Celecoxib: A clinical control study.

Trial Profile

Treatment of gastric precancerous change by Celecoxib: A clinical control study.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 21 May 2012

At a glance

  • Drugs Celecoxib (Primary) ; Amoxicillin; Clarithromycin; Esomeprazole; Helicobacter pylori eradication therapies
  • Indications Gastric atrophy; Gastric cancer; Helicobacter pylori infections
  • Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 21 May 2012 Planned end date 30 Jun 2009 added as reported by Chinese Clinical Trial Register record.
    • 25 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top